Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Synthesis and Regulation of Thyroid Hormones01:20

Synthesis and Regulation of Thyroid Hormones

4.2K
Low blood levels of the thyroid hormones — triiodothyronine (T3) and thyroxine (T4) — signal the hypothalamus to release the thyrotropin-releasing hormone (TRH). TRH then reaches the pituitary gland and stimulates the release of thyroid-stimulating hormone(TSH) into the bloodstream.
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The...
4.2K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Germline CDK12 variants in aggressive prostate cancer.

Cancer discovery·2026
Same author

Fusion of Clinical and Deep Learning Features for Predicting Pembrolizumab Monotherapy Response in Advanced Non-Small Cell Lung Cancer.

Journal of clinical medicine·2026
Same author

Structured Exercise Program After Adjuvant Chemotherapy for Colon Cancer: A Cost-Utility Analysis of the CHALLENGE Trial.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026
Same author

"Where do I go from here?" Navigating a lifelong road without a map: the care experiences of hereditary cancer patients.

European journal of human genetics : EJHG·2026
Same author

Risk of Breast Cancer After Ovarian Cancer in Women With a Pathogenic/Likely Pathogenic Variant in <i>BRCA1</i> or <i>BRCA2</i>.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026
Same author

Prospective multicenter study of ctDNA versus tumor tissue guiding FGFR-targeted therapy in metastatic urothelial cancer.

Nature communications·2026

相关实验视频

Updated: Jun 6, 2025

Spontaneous Murine Model of Anaplastic Thyroid Cancer
05:39

Spontaneous Murine Model of Anaplastic Thyroid Cancer

Published on: February 3, 2023

1.6K

共识声明:关于用于甲状腺癌管理的可操作生物标志物测试的建议

Ozgur Mete1, Andrée Boucher2, Kasmintan A Schrader3

  • 1Department of Pathology, University Health Network, Toronto General Hospital, University of Toronto, Toronto, Ontario, M5G 2C4, Canada. ozgur.mete2@uhn.ca.

Endocrine pathology
|November 23, 2024
PubMed
概括

可操作的生物标志物测试对于甲状腺癌管理至关重要,但面临不一致性. 这项研究提供了共识算法和建议,以指导医生有效地将这些测试应用于向治疗.

关键词:
阿尔克 (ALK) 是一个这就是BRAF.俄罗斯国家广播电视台 (NTRK)拉斯拉斯拉斯拉斯拉斯拉斯拉斯拉斯拉斯在RET的基础上,RET是RET.算法算法是一种算法.生物标志物 生物标志物癌症管理 癌症管理家族性甲状腺癌 (Family Thyroid Carcinoma) 是一种家族性甲状腺癌.基因检测是一种基因检测.在IHC中,IHC是指IHC.免疫组织化学 免疫组织化学骨髓甲状腺癌是一种甲状腺癌.微卫星的不稳定性是微观的纠正不匹配的修复方法分子测试是分子测试.国家储备系统 (NGS)这是下一代测序.在PD-L1中.预测性的 预测性的有针对性的治疗.甲状腺癌是什么?甲状腺癌是什么?瘤的突变负担

更多相关视频

A Blood-based Test for the Detection of ROS1 and RET Fusion Transcripts from Circulating Ribonucleic Acid Using Digital Polymerase Chain Reaction
10:35

A Blood-based Test for the Detection of ROS1 and RET Fusion Transcripts from Circulating Ribonucleic Acid Using Digital Polymerase Chain Reaction

Published on: April 5, 2018

10.3K
Establishment and Characterization of Patient-Derived Xenograft Models of Anaplastic Thyroid Carcinoma and Head and Neck Squamous Cell Carcinoma
06:08

Establishment and Characterization of Patient-Derived Xenograft Models of Anaplastic Thyroid Carcinoma and Head and Neck Squamous Cell Carcinoma

Published on: June 2, 2023

1.7K

相关实验视频

Last Updated: Jun 6, 2025

Spontaneous Murine Model of Anaplastic Thyroid Cancer
05:39

Spontaneous Murine Model of Anaplastic Thyroid Cancer

Published on: February 3, 2023

1.6K
A Blood-based Test for the Detection of ROS1 and RET Fusion Transcripts from Circulating Ribonucleic Acid Using Digital Polymerase Chain Reaction
10:35

A Blood-based Test for the Detection of ROS1 and RET Fusion Transcripts from Circulating Ribonucleic Acid Using Digital Polymerase Chain Reaction

Published on: April 5, 2018

10.3K
Establishment and Characterization of Patient-Derived Xenograft Models of Anaplastic Thyroid Carcinoma and Head and Neck Squamous Cell Carcinoma
06:08

Establishment and Characterization of Patient-Derived Xenograft Models of Anaplastic Thyroid Carcinoma and Head and Neck Squamous Cell Carcinoma

Published on: June 2, 2023

1.7K

科学领域:

  • 在瘤学瘤学.
  • 遗传学 遗传学 是一个
  • 分子诊断学 分子诊断学

背景情况:

  • 甲状腺癌的治疗正在随着生殖线和体质生物标志物测试的整合而发展.
  • 目前的生物标志物测试方法存在缺陷和差异,导致患者护理不一致.
  • 可操作的生物标志物是指导各种甲状腺癌亚型的向治疗选择的关键.

研究的目的:

  • 为甲状腺癌患者制定一致的生物标记测试算法和建议.
  • 解决当前甲状腺癌生物标志物检测策略中的差距和差异.
  • 为医生提供实用指导,以解决针对性治疗的生物标志物测试的复杂性.

主要方法:

  • 召集专家小组,建立共识算法和建议.
  • 进行关于甲状腺癌生物标志物测试的国际指导方针的审查.
  • 进行文献审查,以评估支持甲状腺癌可操作生物标志物的证据.

主要成果:

  • 为甲状腺癌生物标志物测试开发共识驱动的算法和建议.
  • 确定当前测试环境中的关键挑战和缺口.
  • 强调多学科的团队方法,以获得最佳的患者护理.

结论:

  • 开发的算法和建议旨在协助医生进行甲状腺癌生物标志物测试.
  • 这些指导方针平衡了先进护理与实际可行性,考虑了经济和司法因素.
  • 建议是治疗不可知的,确保在不同类型的甲状腺癌中广泛适用.